Could Increasing the Duration of Triple Therapy Be a Clinically Useful Strategy?

  1. Lorenzo Fuccio, MD;
  2. Rocco Maurizio Zagari, MD; and
  3. Franco Bazzoli, MD
  1. From University of Bologna, Bologna 40138, Italy.

    IN RESPONSE:

    We appreciate the comments of Dr. Calvet and colleagues, who disagree with our conclusion that prolonging triple therapy is unlikely to be a clinically useful strategy.

    One of the aims of our meta-analysis was to verify whether current European and U.S. recommendations (1, 2) that support 14 days as the duration of choice reflect the available data. Undoubtedly, …

    « Previous | Next Article »Table of Contents